Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Substance Abuse Treatment, Prevention, and Policy
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2013

Open Access 01-12-2013 | Research

Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers

Authors: Katherine Lang, Jaycie Neil, Judith Wright, Colleen Anne Dell, Shawna Berenbaum, Anas El-Aneed

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2013

Login to get access

Abstract

Background

People who inject drugs (PWID) often encounter barriers when attempting to access health care and social services. In our previous study conducted to identify barriers to accessing care from the perspective of PWIDs in Saskatoon, Canada: poverty, lack of personal support, discrimination, and poor knowledge and coordination of service providers among other key barriers were identified. The purpose of the present investigation was to explore what service providers perceive to be the greatest barriers for PWIDs to receive optimal care. This study is an exploratory investigation with a purpose to enrich the literature and to guide community action.

Methods

Data were collected through focus groups with service providers in Saskatoon. Four focus groups were held with a total of 27 service providers. Data were transcribed and qualitative analysis was performed. As a result, concepts were identified and combined into major themes.

Results

Four barriers to care were identified by service providers: inefficient use of resources, stigma and discrimination, inadequate education and the unique and demanding nature of PWIDs. Participants also identified many successful services.

Conclusion

The results from this investigation suggest poor utilization of resources, lack of continuing education of health care providers on addictions and coping skills with such demanding population, and social stigma and disparity. We recommend improvements in resource utilization through, for example, case management. In addition, sensitivity training and more comprehensive service centers designed to meet PWID’s complex needs may improve care. However, community-wide commitment to addressing injection drug issues will also be required for lasting solutions.
Appendix
Available only for authorised users
Literature
1.
Vlahov D, Wang CL, Galai N, Bareta J, Mehta SH, Strathdee SA: Mortality risk among new onset injection drug users. Addiction. 2004, 99: 946-954. 10.1111/j.1360-0443.2004.00780.x.CrossRefPubMed
2.
Bargagli AM, Sperati A, Davoli M, Forastiere F, Perucci CA: Mortality among problem drug users in Rome: an 18-year follow-up study, 1980–97. Addiction. 2001, 96: 1455-1463. 10.1046/j.1360-0443.2001.961014559.x.CrossRefPubMed
3.
Haber PS, Demirkol A, Lange K, Murnion B: Management of injecting drug users admitted to hospital. Lancet. 2009, 374: 1284-1293. 10.1016/S0140-6736(09)61036-9.CrossRefPubMed
4.
Contoreggi C, Rexroad VE, Lange WR: Current management of infectious complications in the injecting drug user. J Subst Abuse Treat. 1998, 15: 95-106. 10.1016/S0740-5472(97)00048-2.CrossRefPubMed
5.
Chitwood DD, McBride DC, French MT, Comerford M: Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999, 34: 727-746. 10.3109/10826089909037240.CrossRefPubMed
6.
Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML: Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend. 2006, 81: 167-178. 10.1016/j.drugalcdep.2005.06.008.CrossRefPubMed
7.
Morrison A, Elliott L, Gruer L: Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 1997, 92: 1349-1352. 10.1111/j.1360-0443.1997.tb02853.x.CrossRefPubMed
8.
Appel PW, Ellison AA, Jansky HK, Oldak R: Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse. 2004, 30: 129-153. 10.1081/ADA-120029870.CrossRefPubMed
9.
Drumm RD, McBride DC, Metsch L, Page JB, Dickerson K, Jones B: “The rock always comes first”: drug users’ accounts about using formal health care. J Psychoactive Drugs. 2003, 35: 461-469. 10.1080/02791072.2003.10400493.CrossRefPubMed
10.
Gustafson DL, Goodyear L, Keough F: When the dragon’s awake: a needs assessment of people injecting drugs in a small urban centre. Int J Drug Policy. 2008, 19: 189-194. 10.1016/j.drugpo.2008.01.005.CrossRefPubMed
11.
Lally MA, Montstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM: A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care STDS. 2008, 22: 53-64. 10.1089/apc.2006.0206.PubMedCentralCrossRefPubMed
12.
Neale J, Tompkins C, Sheard L: Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community. 2008, 16: 147-154.CrossRefPubMed
13.
Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, O’Shaughnessy MV: Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy. 2002, 13: 95-102. 10.1016/S0955-3959(02)00008-7.CrossRef
14.
Lang K, El-Aneed A, Berenbaum S, Dell CA, Wright J, McKay ZT: Qualitative assessment of crisis services among persons using injection drugs in the city of Saskatoon. J Subst Use. 2011, 18: 311-
15.
Ahern J, Stuber J, Galea S: Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007, 88: 188-196. 10.1016/j.drugalcdep.2006.10.014.CrossRefPubMed
16.
McLaughlin DF, McKenna H, Leslie JC: The perceptions and aspirations illicit drug users hold toward health care staff and the care they receive. J Psychiatr Ment Health Nurs. 2000, 7: 435-441. 10.1046/j.1365-2850.2000.00329.x.CrossRefPubMed
17.
Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA: Mutual mistrust in the medical care of drug users: the keys to the “narc” cabinet. J Gen Intern Med. 2002, 17: 327-333.PubMedCentralPubMed
18.
Telfer I, Clulow C: Heroin misusers: what they think of their general practitioners. Br J Addict. 1990, 85: 137-140. 10.1111/j.1360-0443.1990.tb00633.x.CrossRefPubMed
19.
Chan KY, Reidpath DD: Stigmatization of patients with AIDS: understanding the interrelationships between thai nurses’ attitudes toward HIV/AIDS, drug use, and commercial sex. AIDS Patient Care STDS. 2007, 21: 763-775. 10.1089/apc.2007.0004.CrossRefPubMed
20.
Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD: Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med. 2005, 165: 618-623. 10.1001/archinte.165.6.618.CrossRefPubMed
21.
Carroll J: Attitudes of professionals to drug abusers. Br J Nurs. 1993, 2: 705-711. Jul 22-Aug 11PubMed
22.
Roche AM, Guray C, Saunders JB: General practitioners’ experiences of patients with drug and alcohol problems. Br J Addict. 1991, 86: 263-275. 10.1111/j.1360-0443.1991.tb01779.x.CrossRefPubMed
23.
Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D: Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clin Infect Dis. 2004, 38: 438-441. 10.1086/381095.CrossRefPubMed
24.
Galea S, Factor SH, Palermo AG, Aaron D, Canales E, Vlahov D: Access to resources for substance users in Harlem, New York city: service provider and client perspectives. Health Educ Behav. 2002, 29: 296-311. 10.1177/109019810202900303.CrossRefPubMed
25.
Lewis BA, Koester SK, Bush TW: Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc. 2002, 42: S46-S51.CrossRef
26.
Taussig J, Junge B, Burris S, Jones TS, Sterk CE: Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002, 42: S40-S45.
27.
Strike CJ, Challacombe L, Myers T, Millson M: Needle exchange programs. Delivery and access issues. Can J Public Health. 2002, 93: 339-343.PubMed
28.
Iskandar S, Kamal R, De Jong CA: Psychiatric comorbidity in injecting drug users in Asia and Africa. Curr Opin Psychiatry. 2012, 25: 213-10.1097/YCO.0b013e3283523d66.CrossRefPubMed
29.
de Bruin P, Gibson S, Trischuk H: Saskatoon Health Region HIV Prevention, Treatment & Support Strategy. 2010, Saskatoon: Saskatoon Health Region
30.
Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S: Physicians’ Knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007, 84: 126-136. 10.1007/s11524-006-9120-z.PubMedCentralCrossRefPubMed
31.
Peterson G, Northeast S, Jackson S, Fitzmaurice K: Harm minimization strategies: opinions of health professionals in rural and remote Australia. J Clin Pharm Ther. 2007, 32: 497-504. 10.1111/j.1365-2710.2007.00857.x.CrossRefPubMed
32.
Morgan DL: Focus groups as qualitative research vol. 16. 1997, Thousand Oaks, CA: Sage Publications, Inc
33.
Lin C, Wu Z, Rou K, Pang L, Cao X, Shoptaw S: Challenges in providing services in methadone maintenance therapy clinics in China: Service providers’ perceptions. Int J Drug Policy. 2010, 21: 173-178. 10.1016/j.drugpo.2009.09.002.PubMedCentralCrossRefPubMed
34.
McLaughlin D, McKenna H, Leslie J, Moore K, Robinson J: Illicit drug users in Northern Ireland: perceptions and experiences of health and social care professionals. J Psychiatr Ment Health Nurs. 2006, 13: 682-686. 10.1111/j.1365-2850.2006.01015.x.CrossRefPubMed
35.
Pelet A, Besson J, Pécoud A, Favrat B: Difficulties associated with outpatient management of drug abusers by general practitioners. A cross-sectional survey of general practitioners with and without methadone patients in Switzerland. BMC family practice. 2005, 6: 51-10.1186/1471-2296-6-51.PubMedCentralCrossRefPubMed
36.
Wardman D, Quantz D: Harm reduction services for British Columbia’s First Nation population: a qualitative inquiry into opportunities and barriers for injection drug users. Harm Reduction J. 2006, 3: 30-10.1186/1477-7517-3-30.CrossRef
37.
Deering DEA, Sheridan J, Sellman JD, Adamson SJ, Pooley S, Robertson R: Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addictive behaviors. 2011, 36: 636-642. 10.1016/j.addbeh.2011.01.004.CrossRefPubMed
38.
Li L, Lin C, Wu Z, Wu S, Rotheram-Borus MJ, Detels R: Stigmatization and shame: consequences of caring for HIV/AIDS patients in China. AIDS Care. 2007, 19: 258-263. 10.1080/09540120600828473.PubMedCentralCrossRefPubMed
39.
Krueger RA, Casey MA: Focus groups: a practical guide for applied research. 2009, Thousand Oaks, CA: Sage Publications, Inc.
40.
Hausmann LRM, Jeong K, Bost JE, Ibrahim SA: Perceived discrimination in health care and health status in a racially diverse sample. Med Care. 2008, 46: 905-914. 10.1097/MLR.0b013e3181792562.PubMedCentralCrossRefPubMed
41.
Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD: Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis. 2005, 40 (Suppl 5): S276-S285.PubMedCentralCrossRefPubMed
42.
Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL: Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003, 114: 573-580. 10.1016/S0002-9343(03)00093-7.CrossRefPubMed
43.
Brener L, Von Hippel W, Kippax S: Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?. Int J Drug Policy. 2007, 18: 381-387. 10.1016/j.drugpo.2007.01.006.CrossRefPubMed
44.
Mejta CL, Bokos PJ, Mickenberg J, Maslar ME, Senay E: Improving substance abuse treatment access and retention using a case management approach. J Drug Issues. 1997, 27: 329-340.
45.
Sherer R, Stieglitz K, Narra J, Jasek J, Green L, Moore B: HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care. 2002, 14 (Suppl 1): S31-S44.CrossRefPubMed
46.
Martin N: A time for action tackling stigma and discrimination: report to the Mental Health Commission of Canada. 2007, Ottawa, Ontario: Mental Health Commission of Canada
47.
Gibson M, Munn E, Beatty D, Pugh A: Beyond the label. 2005, Centre for Addiction and Mental Health
Metadata
Title
Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers
Authors
Katherine Lang
Jaycie Neil
Judith Wright
Colleen Anne Dell
Shawna Berenbaum
Anas El-Aneed
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2013
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/1747-597X-8-35

Other articles of this Issue 1/2013

Substance Abuse Treatment, Prevention, and Policy 1/2013 Go to the issue

Research

Factors associated with smoking among adolescent males prior to incarceration and after release from jail: a longitudinal study

Research

Drug use and treatment success among gang and non-gang members in El Salvador: a prospective cohort study

Research

Four-year prospective evaluation of the relationship between meaning in life and smoking status

Short Report

Driving and legal status of Spanish opioid-dependent patients

Research

Factors associated with self-assessed increase in tobacco consumption among over-indebted individuals in Germany: a cross-sectional study

Research

Impact of system-level changes and training on alcohol screening and brief intervention in a family medicine residency clinic: a pilot study